Search

everythinglearnresearchcommunity

for

Search:↓

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Immune cells are essential for early hair and skin development and healing.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

EH-MSCs may help treat hair loss by reducing inflammation.

Targeting specific cell interactions may help treat skin fibrosis.

New insights into cell communication in psoriasis suggest innovative drug treatments.